Found 8 matching trials
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
PHASE1This study is the single-center, open-label phase I clinical trial to evalu...
Location
Hunan Cancer Hospital
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate
PHASE1To assess the safety and efficacy of third-line and above therapy of patien...
Location
The First Affiliated Hospital of College of Medicine Zhejiang University
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
PHASE1This is a Multi-center, Open-labe, Phase I/II Study to evaluate the safety ...
Location
The Second Affiliated Hospital of Army Medical University
A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
NAThis is a randomized, open-label study to evaluate the safety and efficacy ...
Location
Changsha Taihe Hospital
Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer
PHASE1This open-label, one-center, noncomparative, two-stage phase 1B trial asses...
Location
The Affiliated Hospital of Nanjing University Medical School
A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
PHASE1This open-label, one-center, noncomparative, two-stages phase 1B trial asse...
Location
Affiliated Cancer Center of Academy of Military Medical Sciences
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
PHASE1This study is an open, multi-center phase I/II clinical study....
Location
No.81 Hospital of PLA
A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
PHASE1This study is an open, multi-center clinical trial, the purpose is to study...
Location
Zhongshan Hospital Affiliated to Fudan University